External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy
Author(s) -
Satya Das,
Aman Chauhan,
Liping Du,
Katharine Thomas,
Aasems Jacob,
Aimee Schad,
Shikha Jain,
Aaron Jessop,
Chirayu Shah,
David Eisner,
Dana B. Cardin,
Kristen K. Ciombor,
Laura W. Goff,
Marques L. Bradshaw,
Dominique Delbeke,
Martin P. Sandler,
Robert A. Ramirez,
Jordan Berlin
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2021.44170
Subject(s) - radionuclide therapy , medicine , cohort , sunitinib , neuroendocrine tumors , everolimus , capecitabine , progression free survival , oncology , cancer , overall survival , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom